Hester Biosciences share news, announcements and annual reports
NSE: HESTERBIOBSE: 524669Pharmaceuticals & BiotechnologySmall Cap
Hester Biosciences Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Oct 1994 on BSE, Mar 2015 on NSE
Last close ₹2,289.30down ₹18.30 (0.79%)BSE ₹2,299.80
Share price at the NSE close on 30 Oct 2026. Previous close ₹2,307.60.
30 Oct: open ₹2,258.50, high ₹2,327.50, low ₹2,258.50
52-week range of traded prices to 30 Oct 2026
₹1,239.30Low, 30 Mar 2026₹2,683.60High, 30 Jul 2026
- Next results date: the board meets on 5 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,947 Cr1,322nd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 14.30
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes ₹88 crore of one-off items, the largest of them in the quarter to Jun 2026.
- 40.66
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 5.41
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.48%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 40.4%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes ₹88 crore of one-off items, the largest of them in the quarter to Jun 2026.
- 14.2%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 11.7%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.51
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 1,98458.3% delivered
Hester Biosciences share news and announcements
502 announcements, routine notices left out, newest first. Page 5 of 11.
Jan 2022
20 Jan · Board meeting
19 Jan · Rating
Dec 2021
Nov 2021
13 Nov · Board meeting
9 Nov · Business
1 Nov · Meeting
Oct 2021
28 Oct · Results
28 Oct · Board meeting
22 Oct · Analysts
20 Oct · Board meeting
Aug 2021
17 Aug · Analysts
12 Aug · Results
12 Aug · Board meeting
9 Aug · Analysts
4 Aug · Board meeting
Jul 2021
23 Jul · Meeting
Jun 2021
16 Jun · Analysts
8 Jun · Dividend
8 Jun · Results
4 Jun · Analysts
May 2021
30 May · Board meeting
15 May · Updates
15 May · Legal
The exchange asked on 14 May 2021
Apr 2021
16 Apr · Legal
Significant increase in volume has been observed in Hester Biosciences Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited.
Mar 2021
23 Mar · Legal
The exchange asked on 22 Mar 2021
Feb 2021
8 Feb · Analysts
3 Feb · Meeting
Jan 2021
30 Jan · Results
30 Jan · Board meeting
27 Jan · Analysts
21 Jan · Board meeting